Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

Vitamin D and its receptor are essential for hair growth, cell regulation, immune function, and heart health.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Aging slows wound healing due to weaker cells and immune response.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Cicatricial alopecia may be caused by immune attacks on hair follicles, gland issues, or stem cell damage.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

Fluconazole is the preferred treatment for deep skin infections in immunocompromised patients.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

The skin and thymus develop similarly to protect and support immunity.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

FOXN1 mutations cause severe immunodeficiency, hair loss, nail issues, and thymus defects.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Different parts of the body have unique immune characteristics in their skin.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.